On the recordJuly 26, 2017
I look forward to hearing the witnesses' views on these issues and whether our existing antitrust laws are equipped to address these antitrust concerns in the FDA approval process.
Source
congress.govEditor's note · Context
Marino emphasizes the need for discussion on antitrust laws related to FDA processes.
Share & report
More from Tom Marino
Apr 26, 2017
I was unable to attend votes on April 25, 2017 and April 26, 2017 due to a family medical issue. Had I been present, I would have voted as follows: ``Yea'' for rollcall vote 222. ``Yea'' for rollcall vote 223. ``Yea'' for rollcall vote…
Jan 5, 2017
This amendment renders congressional findings on climate change and requires that agencies report to Congress on greenhouse gas impacts associated with a rule. It also requires agencies to report on a rule's effect on low-income and rural…
Jan 11, 2017
I believe in the Constitution just like everyone else does, and primarily we, as congressmen and congresswomen, have a responsibility to make the laws, not unelected bureaucrats who have no experience in a lot of the areas where they are…
Jun 28, 2017
Hills & Company Letter submitted by the Honorable Tom Marino, Pennsylvania, Chairman, Subcommittee on Regulatory Reform, Commercial and Antitrust Law, Committee on the Judiciary.
Other voices in this conversation
